More info…
LONDON (SHARECAST) – AstraZeneca has received approval from the European Commission (EC) for its schizophrenia and bipolar drug Seroquel XR as an add-on treatment for major depressive episodes where antidepressants havent worked.
Europe backs Astra’s Seroquel XR for depression
Subscribe
Subscribe to our e-mail newsletter to receive updates.
Leave a Reply
You must be logged in to post a comment.
No comments yet.